Dr. Harrison W. Torres, MD
Urology (Urology Physician)
- Medicare participating
At a glance
- Medical school
- Texas Tech University Health Science Center School of Medicine (2019)
- Years since graduation
- 7
- In the NPI registry since
- 2019
- Medicare patients seen, 2024
- 161
Licensed in Texas since 2024, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2019Medical school: Texas Tech University Health Science Center School of Medicine
- 2019Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Urology Physician primary
TX license V0199 (first issued 2024; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Christus Good Shepherd Medical Center Longview, TX
Medical groups
- Christus Trinity Clinic Texas (1,540 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 161
- Services billed
- 348
- Patients’ average age
- 74
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Tamsulosin Hcl Other prescribers in Longview, TX | 61 |
| Finasteride Other prescribers in Longview, TX | 51 |
| Solifenacin Succinate Other prescribers in Longview, TX | 31 |
| Gemtesa (vibegron) Other prescribers in Longview, TX | 18 |
| Sulfamethoxazole-Trimethoprim (sulfamethoxazole/trimethoprim) Other prescribers in Longview, TX | 14 |
| Myrbetriq (mirabegron) Other prescribers in Longview, TX | 13 |
| Oxycodone Hcl Other prescribers in Longview, TX | 12 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 8 companies reported 11 payments worth $348 in total to this clinician.
| Amgen Inc. | $109 |
|---|---|
| Boston Scientific Corporation | $47.60 |
| Urogen Pharma, Inc. | $42.58 |
| Teleflex LLC | $36.72 |
| AstraZeneca Pharmaceuticals LP | $35.06 |
| Medtronic, Inc. | $31.56 |
| Endo USA, Inc. | $24.51 |
| Sumitomo Pharma America, Inc. | $21.34 |
| Food and Beverage | $313 |
|---|---|
| Education | $35.06 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP Nov 13, 2025 | Education IMFINZI · Oncology · in-kind Company’s descriptionJournal Article | $35.06 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.